Ephedra meeting
HHS Office on Women's Health to hold a public meeting on safety of ephedrine alkaloid-containing dietary supplements beginning Aug. 8, CFSAN says in a "Dear Colleagues" letter June 8. The meeting, to be held in the Washington, D.C. area, will last for two or three days. A Federal Register notice will provide specific scientific issues to be addressed; possible regulatory actions are not on the agenda. The meeting announcement will be posted on OWH's Web site (www.4woman.gov) on or about June 26. FDA has extended until July 3 the deadline for submitting new usage data and scientific evidence on ephedrine alkaloid-containing supplements; post-meeting comments will be accepted until Sept. 30 (1"The Tan Sheet" May 15, In Brief)
More from Archive
More from Pink Sheet
Eli Lilly is seeking an injunction barring a weight loss clinic from dispensing modified versions of its GLP-1 products.
Analysts expect a limited impact on South Korean pharma from US tariffs, even if imposed at a later date. Meanwhile, the early June domestic presidential election is set to determine the direction of policies in the sector.